The bid by Lilly for the biotechnology company beat out an offer from Bristol-Myers Squibb, which markets ImClone’s cancer drug Erbitux in the United
Discuss Add this link to... Bury
Discuss Add this link to... Bury
NYTBuzz.com is a place where you can discuss all New York Times' content with fellow nyt'rs...
Comments